Archbow Consulting

Overview

Archbow Consulting is a market-access operations consultancy that helps pharma and biotech manufacturers design distribution networks, patient access hubs, and market-access operating models. It is best understood as an execution-oriented access partner, not a hub operator, specialty pharmacy, 3PL, or software platform.

Archbow became part of Omnicom Health Group in 2021 and operates in the Entrée Health / Omnicom Health Market Access ecosystem. That ownership gives buyers access to broader value, access, reimbursement, and communications capabilities while leaving Archbow’s core buying reason intact: senior operating judgment around the access machinery that has to work after a launch strategy is approved.

For a launch team, Archbow is most relevant when the hard questions are practical: which distribution model fits the product, how limited or open the specialty network should be, how the patient hub should be designed, how affordability and coverage workflows should be routed, and how pricing, FMV, GTN, and wholesaler economics should be pressure-tested before contracting.

Market Access Capability Model

The framework below standardizes how Rx Almanac evaluates market-access-consulting capabilities, so buyers can compare vendors like-for-like while the readout column stays vendor-specific. For this table, Archbow Consulting is evaluated as market-access operations consultancy that helps pharma and biotech manufacturers design distribution networks, patient access hubs, and market-access operating models.

Capability	Buyer should compare	Archbow Consulting readout
Payer landscape and access strategy	Payer segmentation, formulary expectations, coverage barriers, benefit design, and access scenario planning.	Execution-oriented fit. Archbow is credible when payer strategy has to translate into a working distribution, hub, and patient-support operating model.
Pricing, contracting, and GTN strategy	WAC strategy, rebate design, contracting scenarios, GTN forecasting, channel economics, and net-price risk.	Documented managed-markets lane. Archbow-authored market commentary and FMV work support a fit for GTN, FMV, wholesaler-fee, and contracting diligence.
HEOR, value dossiers, and evidence planning	Budget impact, cost-effectiveness, AMCP dossier, evidence gaps, PRO endpoints, and value story.	Pair with a value-evidence specialist when needed. Archbow’s center of gravity is access operations and channel economics, not standalone HEOR dossier production.
Payer engagement and message testing	Ad boards, mock P&T, payer research, message testing, objection handling, and stakeholder mapping.	Validate primary-research depth. Omnicom’s access network can extend payer and communications reach, but the Archbow-specific scope should define who owns payer input versus operational design.
Policy, IRA, Medicaid, and channel strategy	IRA, Medicaid, 340B, Medicare, specialty channel, distribution, and policy-risk implications.	Strong channel fit. Best fit is specialty distribution, 3PL, hub, FMV, ASP, and access-operations questions where policy exposure changes the commercial workflow.
Launch sequencing and execution support	Cross-functional launch planning, access playbooks, field tools, governance, and implementation support.	Core fit. Archbow should be in the set when the buyer needs launch access decisions converted into vendor requirements, workflows, network design, and operating governance.

Buyer Fit

• When it belongs in the set: Include Archbow when distribution architecture, specialty pharmacy network design, patient access hub setup, hub redesign, or channel-contracting diligence is central to the launch.
• Therapy and product fit: The profile is therapeutic-agnostic. Strongest fit is for specialty products, complex benefit designs, high-cost therapies, constrained distribution, or launches where patient support and channel economics carry material access risk.
• Commercial fit: Pricing is Custom/RFP. Scope should define whether Archbow is advising on strategy, building implementation requirements, supporting vendor selection, designing workflows, or staying involved through launch execution.
• Parent-network fit: Omnicom Health Market Access context is useful when the buyer wants adjacent value communications, payer marketing, reimbursement, analytics, or training work in the same broader network.
• Coverage diligence: Confirm exactly which Archbow principals will be staffed, how much work is performed by the broader Omnicom access network, and where Archbow’s responsibility ends before hub, SP, 3PL, payer, or agency partners take over.

Differentiators

• Access-operations depth: Archbow’s buying reason is practical access execution: distribution design, patient services, hub workflow, specialty channel, and market-access operations.
• Operator-heavy bench: The public acquisition materials emphasize experience across payers, PBMs, specialty pharmacies, wholesalers, hubs, 3PLs, distributors, and hospitals.
• Omnicom market-access adjacency: Entrée Health and Omnicom Health Market Access can extend Archbow’s work into value communications, payer marketing, reimbursement support, branding, and training when the scope needs it.
• Digital patient-support thesis: Archbow’s public market-access commentary addresses digital health, AI, and automation pressure on traditional hub models.
• Clear operating boundary: Archbow designs and optimizes the model; buyers still need the downstream vendors that operate hubs, pharmacies, logistics, copay programs, and patient engagement at scale.

RFP Questions

• Which distribution, specialty pharmacy, hub, 3PL, payer, and wholesaler analogs has the proposed team handled in the last three years?
• What deliverables will the team produce: strategy memo, network design, vendor scorecard, hub workflow map, contracting model, operating SOP, implementation roadmap, or launch governance plan?
• How will Archbow separate advice about channel design from downstream vendor selection and implementation handoffs?
• Which FMV, ASP, wholesaler-fee, GTN, contracting, and compliance assumptions will be documented for legal, finance, and market-access review?
• If Omnicom Health Market Access capabilities are included, which entity owns each workstream and how will conflicts between strategy, communications, and implementation partners be managed?
• What post-launch monitoring or optimization support is included once claims, hub, pharmacy, wholesaler, and patient-support data start flowing?

Recent Activity

• April 2026: PharmaLive profiled Omnicom Health Market Access as a combined access and reimbursement offering that includes Archbow, Entrée Health, McCann Health Managed Markets, Mosaic Group, and Valuate Health Consultancy.
• January 2025: Archbow principals published market-access commentary on digital health, AI-enabled patient support, GTN erosion, GLP-1 access pressure, FMV, and distribution-services negotiation leverage.
• 2021: Omnicom Health Group acquired Archbow Consulting and placed the firm inside the Entrée Health network, extending Omnicom’s value and access capabilities into distribution and patient-services operations.